Division of Hematology/Oncology

Clinical/Translational Research

Genitourinary (GU) Cancer Research Program

Program Leaders:
Naomi Haas, MD, Stephen Keefe, MD
David Vaughn, MD

The Medical Oncology Genitourinary Research Program provides compassionate multidisciplinary care that is informed by research into the most effective therapies for genitourinary cancer. Penn physicians conduct clinical research and other investigations to improve the ability to diagnose and treat patients with all types of genitourinary malignancies including bladder, prostate, renal, and testicular cancers. It is through such research that clinicians improve current treatment and develop future cancer treatments and care.

Penn physicians conduct a variety of ongoing clinical research studies, usually in close collaboration with other departments and divisions, including radiation oncology and urology.

These studies include:

  • Assessment of new therapies for all stages of disease, including studies combining surgery, radiation and chemotherapy.
  • Assessment of new experimental agents for the treatment of patients with genitourinary cancer, including phase 1 clinical trials.
  • Quality-of-life studies.
  • Analysis of tissue, blood, and tumor samples to better understand the biology of the malignancies and relationship to patient outcomes (for example, our testicular cancer genetic susceptibility study).

Patients with genitourinary cancer may be asked to participate in a variety of research studies. Learn more about participating in a clinical trial for genitourinary cancer

Medical oncologists involved in the management of genitourinary cancer include:

Loading Provider List...